DLHC vs CASS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 23, 2026

DLHC

52.3
AI Score
VS
DLHC Wins

CASS

43.7
AI Score

Investment Advisor Scores

DLHC

52score
Recommendation
STRONG BUY

CASS

44score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric DLHC CASS Winner
Forward P/E 17.452 18.622 DLHC
PEG Ratio 1.1263 0 Tie
Revenue Growth -46.9% 12.2% CASS
Earnings Growth -75.0% 24.3% CASS
Tradestie Score 52.3/100 43.7/100 DLHC
Profit Margin -8.5% 17.1% CASS
Beta 1.00 1.00 Tie
AI Recommendation STRONG BUY HOLD DLHC

Relative Price Performance (Last 90 Days)

DLHC 1M: -10.7% · 3M: -18.4% CASS 1M: +4.5% · 3M: +21.3%

Current Technical Phase

DLHC

Markdown
Sell / avoid

Price below a falling SMA50 (slope -5.4%), weak momentum, RSI 34

RSI (14): 33.6 · Price: $4.53

CASS

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (8.4% over 20 days), RSI 53

RSI (14): 53.4 · Price: $56.40

Fundamentals Snapshot

Metric DLHC CASS
Market Cap
Forward P/E -6.6 15.6
Trailing P/E 20.5
Revenue (TTM)
Revenue Growth -0.5% 0.1%
Gross Margin 0.2% 0.5%
Operating Margin -0.1% 0.3%
EPS -1.49 2.78
Dividend Yield 0.02%

Frequently Asked Questions

Based on our detailed analysis, DLHC is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.